Connection

AYSE MINDIKOGLU to Humans

This is a "connection" page, showing publications AYSE MINDIKOGLU has written about Humans.
Connection Strength

0.430
  1. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. 2020 10 27; 10(1):18341.
    View in: PubMed
    Score: 0.020
  2. Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects. J Proteomics. 2020 04 15; 217:103645.
    View in: PubMed
    Score: 0.018
  3. Renal Trajectory Patterns Are Associated With Postdischarge Mortality in Patients With Cirrhosis and Acute Kidney Injury. Clin Gastroenterol Hepatol. 2020 07; 18(8):1858-1866.e6.
    View in: PubMed
    Score: 0.018
  4. Predictors of Response to Terlipressin in Hepatorenal Syndrome. Clin Gastroenterol Hepatol. 2018 07; 16(7):1174.
    View in: PubMed
    Score: 0.016
  5. Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675.
    View in: PubMed
    Score: 0.016
  6. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47.
    View in: PubMed
    Score: 0.016
  7. New Developments in Hepatorenal Syndrome. Clin Gastroenterol Hepatol. 2018 02; 16(2):162-177.e1.
    View in: PubMed
    Score: 0.015
  8. Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List. Dig Dis Sci. 2016 Jan; 61(1):309-16.
    View in: PubMed
    Score: 0.014
  9. Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction. Dig Dis Sci. 2015 Nov; 60(11):3491-4.
    View in: PubMed
    Score: 0.014
  10. Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and?Dimethylarginines. Clin Gastroenterol Hepatol. 2016 Apr; 14(4):624-632.e2.
    View in: PubMed
    Score: 0.014
  11. A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements. Am J Nephrol. 2014; 39(6):543-52.
    View in: PubMed
    Score: 0.013
  12. Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States. Transplant Proc. 2014 Jan-Feb; 46(1):219-24.
    View in: PubMed
    Score: 0.012
  13. Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol. 2013; 38(4):345-54.
    View in: PubMed
    Score: 0.012
  14. Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology. 2014 Apr; 59(4):1532-42.
    View in: PubMed
    Score: 0.012
  15. Impact of estimated liver volume and liver weight on gender disparity in liver transplantation. Liver Transpl. 2013 Jan; 19(1):89-95.
    View in: PubMed
    Score: 0.011
  16. Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int. 2012 Apr; 25(4):409-15.
    View in: PubMed
    Score: 0.011
  17. Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis. Transplant Proc. 2011 Sep; 43(7):2669-77.
    View in: PubMed
    Score: 0.010
  18. Valproic acid-associated acute liver failure in children: case report and analysis of liver transplantation outcomes in the United States. J Pediatr. 2011 May; 158(5):802-7.
    View in: PubMed
    Score: 0.010
  19. Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl. 2010 Oct; 16(10):1147-57.
    View in: PubMed
    Score: 0.010
  20. Radiofrequency ablation in patients with hepatocellular carcinoma. Hepatology. 2009 Dec; 50(6):2053; author reply 2053-4.
    View in: PubMed
    Score: 0.009
  21. Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl. 2009 Jul; 15(7):719-29.
    View in: PubMed
    Score: 0.009
  22. Hepatitis C in the elderly: epidemiology, natural history, and treatment. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):128-34; quiz 124.
    View in: PubMed
    Score: 0.009
  23. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation. 2008 Feb 15; 85(3):359-68.
    View in: PubMed
    Score: 0.008
  24. Imatinib mesylate (gleevec) hepatotoxicity. Dig Dis Sci. 2007 Feb; 52(2):598-601.
    View in: PubMed
    Score: 0.008
  25. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention. Clin Gastroenterol Hepatol. 2006 Sep; 4(9):1076-81.
    View in: PubMed
    Score: 0.007
  26. HELLP syndrome complicated bile duct injury and subsequent left hepatic lobe atrophy. Dig Dis Sci. 2006 Jul; 51(7):1206-12.
    View in: PubMed
    Score: 0.007
  27. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation. Transplant Proc. 2006 Jun; 38(5):1440-4.
    View in: PubMed
    Score: 0.007
  28. Multiple normal deliveries in a woman with severe portal hypertension due to congenital hepatic fibrosis: the importance of preserved hepatocellular function. Am J Gastroenterol. 2005 Oct; 100(10):2359-61.
    View in: PubMed
    Score: 0.007
  29. Focal nodular hyperplasia in identical twins. Am J Gastroenterol. 2005 Jul; 100(7):1616-9.
    View in: PubMed
    Score: 0.007
  30. Epithelioid hemangioendothelioma of the liver. Clin Gastroenterol Hepatol. 2005 Jul; 3(7):xxxii.
    View in: PubMed
    Score: 0.007
  31. Post-transplant IVC occlusion and thrombosis treated with tPA, heparin, and sharp recanalization. J Gastroenterol. 2005 Mar; 40(3):302-5.
    View in: PubMed
    Score: 0.007
  32. Evaluation of novel candidate filtration markers from a global metabolomic discovery for glomerular filtration rate estimation. Kidney Int. 2024 Mar; 105(3):582-592.
    View in: PubMed
    Score: 0.006
  33. Prochlorperazine-induced cholestasis in a patient with alpha-1 antitrypsin deficiency. Hepatogastroenterology. 2003 Sep-Oct; 50(53):1338-40.
    View in: PubMed
    Score: 0.006
  34. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa. Hepatogastroenterology. 2003 Sep-Oct; 50(53):1697-9.
    View in: PubMed
    Score: 0.006
  35. Acute intracranial hemorrhage in a cirrhotic controlled with recombinant factor VIIa. Dig Dis Sci. 2003 Jun; 48(6):1130-5.
    View in: PubMed
    Score: 0.006
  36. Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient. Chest. 2003 Mar; 123(3):956-8.
    View in: PubMed
    Score: 0.006
  37. Response to "Reply to: 'The decreasing predictive power of MELD in an era of changing etiology of liver disease'". Am J Transplant. 2020 03; 20(3):903-904.
    View in: PubMed
    Score: 0.005
  38. The decreasing predictive power of MELD in an era of changing etiology of liver disease. Am J Transplant. 2019 12; 19(12):3299-3307.
    View in: PubMed
    Score: 0.005
  39. No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades. Ann Surg. 2019 01; 269(1):20-27.
    View in: PubMed
    Score: 0.004
  40. Predicting Liver Allograft Discard: The Discard Risk Index. Transplantation. 2018 09; 102(9):1520-1529.
    View in: PubMed
    Score: 0.004
  41. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.004
  42. A Surge in cadaveric liver donors and a national narcotic epidemic: Is there an association? Liver Transpl. 2017 05; 23(5):698-700.
    View in: PubMed
    Score: 0.004
  43. Renal dysfunction in cirrhosis. Curr Opin Gastroenterol. 2015 May; 31(3):215-23.
    View in: PubMed
    Score: 0.003
  44. Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis. Med Oncol. 2014 Jun; 31(6):971.
    View in: PubMed
    Score: 0.003
  45. End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection. J Viral Hepat. 2012 May; 19(5):371-6.
    View in: PubMed
    Score: 0.003
  46. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl. 2009 Dec; 15(12):1814-20.
    View in: PubMed
    Score: 0.002
  47. Postoperative infections in cirrhotic patients. Hepatogastroenterology. 2005 Jul-Aug; 52(64):1240-3.
    View in: PubMed
    Score: 0.002
  48. Recombinant human factor VIIa-induced alterations in tissue factor and thrombomodulin in patients with advanced liver cirrhosis. J Gastroenterol Hepatol. 2005 Jun; 20(6):882-9.
    View in: PubMed
    Score: 0.002
  49. Platelet sparing effect of COX II inhibition used with pegylated interferon alfa-2a for the treatment of chronic hepatitis C: a short term pilot study. Cytokine. 2004 Sep 21; 27(6):159-65.
    View in: PubMed
    Score: 0.002
  50. Cardiovascular problems in cirrhotic patients. Turk J Gastroenterol. 2004 Sep; 15(3):126-32.
    View in: PubMed
    Score: 0.002
  51. Coagulation and fibrinolysis in individuals with advanced liver disease. Turk J Gastroenterol. 2004 Jun; 15(2):67-72.
    View in: PubMed
    Score: 0.002
  52. Modulation of endothelial cell inflammatory integrins and stress markers with rh-factor VIIa in patients with advanced chronic hepatitis C. J Viral Hepat. 2003 Jul; 10(4):310-7.
    View in: PubMed
    Score: 0.001
  53. Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci. 2003 Jul; 48(7):1414-24.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.